The inhibition of VEGF significantly suppresses the expression of αvβ3 on tumor cells resulting in the reduction of microvascular density, and so VEGF has been proposed as a potential biomarker of angiogenic activity [44]. The gene discussed is VEGFA; the disease is neoplasm.